Incannex Operating Cycle from 2010 to 2026

IXHL Stock  USD 0.40  0.01  2.56%   
Incannex Healthcare Operating Cycle yearly trend continues to be quite stable with very little volatility. Operating Cycle may rise above about 19.5 K this year. From the period between 2010 and 2026, Incannex Healthcare, Operating Cycle regression line of its data series had standard deviation of  78,122 and standard deviation of  78,122. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
17.7 K
Current Value
19.5 K
Quarterly Volatility
78.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Incannex Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Incannex Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 486.7 K, Interest Expense of 365.9 K or Gross Profit of 86.7 K, as well as many indicators such as Price To Sales Ratio of 94.41, Dividend Yield of 0.0 or PTB Ratio of 0.67. Incannex financial statements analysis is a perfect complement when working with Incannex Healthcare Valuation or Volatility modules.
  
Build AI portfolio with Incannex Stock
Check out the analysis of Incannex Healthcare Correlation against competitors.

Latest Incannex Healthcare's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Incannex Healthcare Ltd over the last few years. It is Incannex Healthcare's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Incannex Healthcare's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Incannex Operating Cycle Regression Statistics

Arithmetic Mean40,506
Geometric Mean2,236
Coefficient Of Variation192.87
Mean Deviation57,519
Median1,911
Standard Deviation78,122
Sample Variance6.1B
Range203.4K
R-Value0.43
Mean Square Error5.3B
R-Squared0.18
Significance0.09
Slope6,644
Total Sum of Squares97.6B

Incannex Operating Cycle History

202619.5 K
202517.7 K
202419.6 K
2021203.5 K
2020 32.52
2019 397.82
2018 122.05

About Incannex Healthcare Financial Statements

Incannex Healthcare investors utilize fundamental indicators, such as Operating Cycle, to predict how Incannex Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Operating Cycle17.7 K19.5 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Incannex Healthcare is a strong investment it is important to analyze Incannex Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Incannex Healthcare's future performance. For an informed investment choice regarding Incannex Stock, refer to the following important reports:
Check out the analysis of Incannex Healthcare Correlation against competitors.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. If investors know Incannex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incannex Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.08)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.30)
Return On Equity
(1.15)
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incannex Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.